These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15111759)

  • 1. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States.
    Schootman M; Jeffe D; Reschke A; Aft R
    Breast Cancer Res Treat; 2004 Jun; 85(3):219-22. PubMed ID: 15111759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
    Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
    Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection and diagnosis of early, occult and minimal breast cancer.
    Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
    Adv Surg; 1976; 10():287-312. PubMed ID: 185891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of three decades of screening mammography on breast-cancer incidence.
    Bleyer A; Welch HG
    N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
    Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
    JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting breast cancer trends in the United States.
    Anderson WF; Reiner AS; Matsuno RK; Pfeiffer RM
    J Clin Oncol; 2007 Sep; 25(25):3923-9. PubMed ID: 17679726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First breast cancer mammography screening program in Mexico: initial results 2005-2006.
    Rodríguez-Cuevas S; Guisa-Hohenstein F; Labastida-Almendaro S
    Breast J; 2009; 15(6):623-31. PubMed ID: 19686232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):485-90. PubMed ID: 9746962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and self breast examination remain important in the era of modern screening.
    Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
    Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
    Vacek PM; Geller BM; Weaver DL; Foster RS
    Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.